XM does not provide services to residents of the United States of America.

Symrise sees 7% annual organic sales growth on boost from fragrance, taste segments



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Symrise sees 7% annual organic sales growth on boost from fragrance, taste segments</title></head><body>

Recasts paragraph 1, adds CEO and analyst quotes in paragraphs 3, 5, 10, adds share moves in paragraph 6, comments on pet food segment and peer's performance in paragraphs 13-14

By Matteo Allievi

Oct 24 (Reuters) -Germany's Symrise SY1G.DE forecast an annual organic sales growth of 7% on Thursday, encouraged by a strong momentum in its fragrance and taste segments, although it expects growth to be likely more modest "at some point".

The flavour and fragrance maker had previously forecast an annual sales growth of 5%-7%.

"Despite the current volatile market environment due to geopolitical tensions and continued inflation pressure, we are confident for the rest of the year and expect robust demand," CEO Jean-Yves Parisot said in a statement.

However, CFO Olaf Klinger warned on a conference call that comparisons are getting tougher and continuing with double-digit growth "would be a surprise".

"The growth we have seen in the sector year-to-date is certainly exceptional. I think everybody is expecting some normalisation next year," said Vontobel analyst Arben Hasanaj.

Shares were down 1.7% at 0739 GMT after falling as much as 3.7%.

Revenue rose more than 5% in the reporting currency to 1.26 billion euros ($1.36 billion) in the quarter ended September, slightly missing analysts' estimates of 1.27 billion euros.

Like-for-like sales jumped 10.2% from a year earlier.

Organic sales in its Taste, Nutrition and Health business, which accounted for more than half of the total, rose 11.3%, while the Scent and Care division posted an 8.4% jump.

"The taste side looks quite good, but in fragrances we see quite a large gap opening up compared to peer's Givaudan GIVN.S," said Hasanaj.

While the rest of the German chemical sector is still facing a sluggish demand in a weaker economy, companies in fragrances and cosmetic business have seen a strong sales increase since the start of 2024.

Symrise, whose fragrances go into the perfumes of French luxury giants LVMH LVMH.PA and Kering PRTP.PA, confirmed its long-term outlook, expecting organic sales growth between 5% and 7% and a core profit margin in the range of 20%-23%.

Concerning the group's pet food segment, Parisot expects prices to continue to stabilise until 2024 end before going back to a more normal environment next year.

Rival Givaudan also reported sales above expectations earlier this month on sustained high demand.


($1 = 0.9271 euros)



Reporting by Matteo Allievi; Editing by Rashmi Aich

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.